E-MTAB-1627 - RNA-seq of coding RNA of human tumour Calu6 and LoVo xenografts with the VEGFR tyrosine kinase inhibitor cediranib to investigate mRNA expression changes induced by treatment

Status
Released on 9 September 2013, last updated on 3 May 2014
Organism
Homo sapiens
Samples (6)
Protocols (5)
Description
Calu6 and LoVo xenograft mRNA expression profiles in response to cediranib treatment
Experiment types
RNA-seq of coding RNA, co-expression, compound treatment human tumour xenografts with the VEGFR tyrosine kinase inhibitor cediranib , in vivo
Contact
Citation
RNA-Seq differentiates tumour and host mRNA expression changes induced by treatment of human tumour xenografts with the VEGFR tyrosine kinase inhibitor cediranib. James R. Bradford, Matthew Farren, Steve J. Powell, Sarah Runswick, Susie L. Weston, Helen Brown, Oona Delpuech, Mark Wappett1 Neil R. Smith, T. Hedley Carr, Jonathan R. Dry, Neil J. Gibson and Simon T. Barry.
MINSEQE
Exp. designProtocolsVariablesProcessedSeq. reads
Files
Investigation descriptionE-MTAB-1627.idf.txt
Sample and data relationshipE-MTAB-1627.sdrf.txt
Links